Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone
Year: 2022
Type: article
Authors: Nicholas Chiu, Rahul Aggarwal, George L. Bakris, Bertram Pitt, Deepak L. Bhatt
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,700
OpenAlex ID: W4220715836
